JP2004521942A - 高純度医薬中間体である4−(シクロプロピルカルボニル)−α,α−ジメチルフェニル酢酸の製造方法 - Google Patents

高純度医薬中間体である4−(シクロプロピルカルボニル)−α,α−ジメチルフェニル酢酸の製造方法 Download PDF

Info

Publication number
JP2004521942A
JP2004521942A JP2003507065A JP2003507065A JP2004521942A JP 2004521942 A JP2004521942 A JP 2004521942A JP 2003507065 A JP2003507065 A JP 2003507065A JP 2003507065 A JP2003507065 A JP 2003507065A JP 2004521942 A JP2004521942 A JP 2004521942A
Authority
JP
Japan
Prior art keywords
formula
cyclopropylcarbonyl
para
compound
meta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003507065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004521942A5 (cg-RX-API-DMAC10.html
Inventor
ラメシュ、ダンダーラ
ウマシャンカル、ダス
ディッヴェーラ、ヴェンカタ、ナガ、スリニヴァサ、ラオ
メーナクシ、スンデラム、シヴァクマラン
Original Assignee
オーロビンド ファーマ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オーロビンド ファーマ リミテッド filed Critical オーロビンド ファーマ リミテッド
Publication of JP2004521942A publication Critical patent/JP2004521942A/ja
Publication of JP2004521942A5 publication Critical patent/JP2004521942A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2003507065A 2001-06-25 2002-06-19 高純度医薬中間体である4−(シクロプロピルカルボニル)−α,α−ジメチルフェニル酢酸の製造方法 Pending JP2004521942A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN511CH2001 2001-06-25
PCT/IN2002/000135 WO2003000658A1 (en) 2001-06-25 2002-06-19 PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID

Publications (2)

Publication Number Publication Date
JP2004521942A true JP2004521942A (ja) 2004-07-22
JP2004521942A5 JP2004521942A5 (cg-RX-API-DMAC10.html) 2005-02-17

Family

ID=29765111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003507065A Pending JP2004521942A (ja) 2001-06-25 2002-06-19 高純度医薬中間体である4−(シクロプロピルカルボニル)−α,α−ジメチルフェニル酢酸の製造方法

Country Status (7)

Country Link
US (1) US6903232B2 (cg-RX-API-DMAC10.html)
EP (1) EP1401815A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004521942A (cg-RX-API-DMAC10.html)
BG (1) BG107476A (cg-RX-API-DMAC10.html)
SI (1) SI21232A (cg-RX-API-DMAC10.html)
SK (1) SK712003A3 (cg-RX-API-DMAC10.html)
WO (1) WO2003000658A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
WO2003104197A1 (en) * 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
DE102004031849A1 (de) 2004-06-30 2006-01-26 Sanofi-Aventis Deutschland Gmbh Verfahren zur Carbonylierung von Phenylalkylderivaten mit Kohlenmonoxid
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
RS59874B1 (sr) 2015-10-22 2020-03-31 Sanofi Aventis Deutschland Proces za pripremu feksofenadina i njegovih intermedijara

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
DK1026147T3 (da) * 1993-06-24 2004-03-22 Albany Molecular Res Inc Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater

Also Published As

Publication number Publication date
SI21232A (sl) 2003-12-31
EP1401815A1 (en) 2004-03-31
US6903232B2 (en) 2005-06-07
SK712003A3 (en) 2003-12-02
WO2003000658A1 (en) 2003-01-03
US20040077900A1 (en) 2004-04-22
BG107476A (bg) 2004-01-30

Similar Documents

Publication Publication Date Title
EP1026147B1 (en) Compounds useful as intermediates in the production of piperidine derivatives
US4902801A (en) Process for preparing aryl-piperidine carbinols and novel intermediates used in the process
AU612621B2 (en) Benzoylpiperidines and benzoylpiperidine oxides and oximes and their preparation
JP4330179B2 (ja) テルフェナジン及び誘導体の合成
JP3686950B2 (ja) ピペリジン誘導体類の新規な方法
JP4344230B2 (ja) ピペリジン誘導体フェキソフェナジンの製造方法
KR20000064387A (ko) 1-벤질-4-((5,6-디메톡시-1-인다논)-2-일)메틸피페리딘을제조하기위한방법및중간체
US6903232B2 (en) Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-α, α-dimethylphenylacetic acid
US20100016601A1 (en) Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for the preparation thereof
AU2002320847A1 (en) Process for the production of the piperidine derivative fexofenadine
JP2004521942A5 (cg-RX-API-DMAC10.html)
JP5585822B2 (ja) 光学活性ニペコチン酸誘導体の製造方法
US7446203B2 (en) Preparation of intermediates for acetycholinesterase inhibitors
US6538138B1 (en) Process and a novel intermediate for the preparation of Flecainide
AU2001278094A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
JPH0521105B2 (cg-RX-API-DMAC10.html)
WO2007135693A2 (en) Intermediates useful for the preparation of antihistaminic piperidine derivative
JPH0681743B2 (ja) α−(アルキルフェニル)−4−(ヒドロキシジフェニルメチル)−1−ピペリジンブタノールの製造方法
US20020133013A1 (en) Process for making cyanomethyl ester precursors of flecainide
AU2008202097A1 (en) A Process for the Preparation of Keto Compounds
WO1995022533A1 (en) Process for producing 3-isoxazolecarboxylic acid
CN101522620A (zh) 制备甲美芳铵的方法
WO2009136412A2 (en) PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF
EP2289867A2 (en) A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060526

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060602

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070105